Human health effects of conjugated linoleic acid from milk and supplements

Nutrition Research Reviews

Volumn 24, Issue 2, 2011, Pages 206-227

  McCrorie, Tracy A ^a   Keaveney, Edel M ^a   Wallace, Julie M W ^a   Binns, Nino ^b   Livingstone, M Barbara E ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b Nino Binns Consulting   (Ireland)

Author keywords

Cis 9, trans 11 conjugated linoleic acid; Conjugated linoleic acid; Milk

Indexed keywords

CONJUGATED LINOLEIC ACID; LIPID; PLACEBO;

ATHEROSCLEROSIS; BODY COMPOSITION; BODY FAT; BONE; BREAST CANCER; COLORECTAL CANCER; DAIRY PRODUCT; DIABETES MELLITUS; DIET; FOOD; FOOD INTAKE; HEALTH; HUMAN; IMMUNITY; INFLAMMATION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID METABOLISM; MILK; NONHUMAN; OBESITY; POSTMENOPAUSE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN CANCER; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS; DIETARY FATS; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; ISOMERISM; LINOLEIC ACIDS, CONJUGATED; MILK; WEIGHT LOSS;

ANIMALIA;

EID: 84858809840     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422411000114     Document Type: Review

References (176)

1. European Parliament and Council of the European Union (2006) Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. In Official Journal of the European Union, pp. L404/9-L404/25, issue no. 1924.
2. Chin S, Liu W, Storkson JM, et al. (1992) Dietary sources of conjugated dienoic isomer of linoleic acid, a newly recognized class of anticarcinogens. J Food Compost Anal 5, 185-197.
3. Banni S (2002) Conjugated linoleic acid metabolism. Curr Opin Lipidol 13, 261-266.
4. Pariza MW, Park Y & Cook ME (2001) The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40, 283-298.
5. Lock AL & Bauman DE (2004) Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids 39, 1197-1206.
6. Christie WW (1999) Analysis of conjugated linoleic acid: An overview. In Advances in Conjugated Linoleic Acid Research, vol. 2, pp. 1-12 [JL Sebedio, WW Christie and RO Adlof, editors]. Champaign, IL: AOCS Press.
7. Ha YL, Grimm NK & Pariza MW (1987) Anticarcinogens from fried ground beef: Heat-altered derivatives of linoleic acid. Carcinogenesis 8, 1881-1887.
8. Ritzenthaler KL, McGuire MK, Falen R, et al. (2001) Estimation of conjugated linoleic acid intake by written dietary assessment methodologies underestimates actual intake evaluated by food duplicate methodology. J Nutr 131, 1548-1554.
9. Mushtaq S, Heather Mangiapane E & Hunter KA (2010) Estimation of cis-9, trans-11 conjugated linoleic acid content in UK foods and assessment of dietary intake in a cohort of healthy adults. Br J Nutr 103, 1366-1374.
10. Parodi PW (2003) Conjugated linoleic acid in food. In Advances in Conjugated Linoleic Acid Research, vol. 2, pp. 101-122 [JL Sebedio, WW Christie and RO Adlof, editors]. Champaign, IL: AOCS Press.
11. Parodi PW (1999) Conjugated linoleic acid: The early years. In Advances in Conjugated Linoleic Acid Research, vol. 1, pp. 1-12 [MP Yurawecz, MM Mossoba, JK Kramer, MW Pariza and GJ Nelson, editors]. Champaign, IL: AOCS Press.
12. Dhiman TR, Anand GR, Satter LD, et al. (1999) Conjugated linoleic acid content of milk from cows fed different diets. J Dairy Sci 82, 2146-2156.
13. Ellis KA, Innocent G, Grove-White D, et al. (2006) Comparing the fatty acid composition of organic and conventional milk. J Dairy Sci 89, 1938-1950.
14. Stanton C, Murphy J, McGrath E, et al (2003) Animal feeding strategies for conjugated linoleic acid enrichment of milk. In Advances in Conjugated Linoleic Acid Research, vol. 2, pp. 123-145 [JL Sebedio, WW Christie and RO Adlof, editors]. Champaign, IL: AOCS Press.
15. Jones EL, Shingfield KJ, Kohen C, et al. (2005) Chemical, physical, and sensory properties of dairy products enriched with conjugated linoleic acid. J Dairy Sci 88, 2923-2937.
16. Burdge GC, Tricon S, Morgan R, et al. (2005) Incorporation of cis-9 trans-11 conjugated linoleic acid and vaccenic acid (trans-11 18 : 1) into plasma and leucocyte lipids in healthy men consuming dairy products naturally enriched in these fatty acids. Br J Nutr 94, 237-243.
17. Parodi PW (1999) Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci 82, 1339-1349.
18. Bhattacharya A, Banu J, Rahman M, et al. (2006) Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17, 789-810.
19. Kelley NS, Hubbard NE & Erickson KL (2007) Conjugated linoleic acid isomers and cancer. J Nutr 137, 2599-2607.
20. Belury MA (1995) Conjugated dienoic linoleate: A polyunsaturated fatty acid with unique chemoprotective properties. Nutr Rev 53, 83-89.
21. Ip C, Chin SF, Scimeca JA, et al. (1991) Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res 51, 6118-6124.
22. Ip C, Singh M, Thompson HJ, et al. (1994) Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res 54, 1212-1215.
23. Palombo JD, Ganguly A, Bistrian BR, et al. (2002) The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett 177, 163-172.
24. Beppu F, Hosokawa M, Tanaka L, et al. (2006) Potent inhibitory effect of trans 9, trans 11 isomer of conjugated linoleic acid on the growth of human colon cancer cells. J Nutr Biochem 17, 830-836.
25. Yasui Y, Suzuki R, Kohno H, et al. (2007) 9-Trans, 11-trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in rats. Nutr Cancer 59, 82-91.
26. Ip C, Banni S, Angioni E, et al. (1999) Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr 129, 2135-2142.
27. Lavillonniere F, Chajes V, Martin JC, et al. (2003) Dietary purified cis-9,trans-11 conjugated linoleic acid isomer has anticarcinogenic properties in chemically induced mammary tumors in rats. Nutr Cancer 45, 190-194.
28. Hubbard NE, Lim D & Erickson KL (2003) Effect of separate conjugated linoleic acid isomers on murine mammary tumorigenesis. Cancer Lett 190, 13-19.
29. Ip MM, McGee SO, Masso-Welch PA, et al. (2007) The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium. Carcinogenesis 28, 1269-1276.
30. Aro A, Mannisto S, Salminen I, et al. (2000) Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr Cancer 38, 151-157.
31. Chajes V, Lavillonniere F, Ferrari P, et al. (2002) Conjugated linoleic acid content in breast adipose tissue is not associated with the relative risk of breast cancer in a population of French patients. Cancer Epidemiol Biomarkers Prev 11, 672-673.
32. Chajes V, Lavillonniere F, Maillard V, et al. (2003) Conjugated linoleic acid content in breast adipose tissue of breast cancer patients and the risk of metastasis. Nutr Cancer 45, 17-23.
33. Voorrips LE, Brants HA, Kardinaal AF, et al. (2002) Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: The Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr 76, 873-882.
34. Larsson SC, Bergkvist L & Wolk A (2009) Conjugated linoleic acid intake and breast cancer risk in a prospective cohort of Swedish women. Am J Clin Nutr 90, 556-560.
35. Larsson SC, Bergkvist L & Wolk A (2005) High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort. Am J Clin Nutr 82, 894-900.
36. McCann SE, Ip C, Ip MM, et al. (2004) Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev 13, 1480-1484.
37. Farnworth ER, Chouinard YP, Jacques H, et al. (2007) The effect of drinking milk containing conjugated linoleic acid on fecal microbiological profile, enzymatic activity, and fecal characteristics in humans. Nutr J 9, 6-15.
38. Venkatramanan S, Chouinard YP, Jacques H, et al. (2010) Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals. J Am Coll Nutr 29, 152-159.
39. World Cancer Research Fund & American Institute for Cancer Research (2007) WCRF/AICR Expert Report, Food, nutrition, physical activity and the prevention of cancer: A global perspective http://www.dietandcancerreport.org/ (accessed 26 October 2009)
40. Craig R & Mindell J (2008) Health Survey for England 2006 Latest Trends. London: The Information Centre.
41. Forsythe LK, Wallace JM & Livingstone MBE (2008) Obesity and inflammation: The effects of weight loss. Nutr Res Rev 21, 117-133.
42. Wahle K, Heys S & Rotondo D (2004) Conjugated linoleic acids: Are they beneficial or detrimental to health? Progr Lipid Res 43, 553-587.
43. Brown JM & McIntosh MK (2003) Conjugated linoleic acid in humans: Regulation of adiposity and insulin sensitivity. J Nutr 133, 3041-3046.
44. Petridou A, Mougios V & Sagredos A (2003) Supplementation with CLA: Isomer incorporation into serum lipids and effect on body fat of women. Lipids 38, 805-811.
45. Tricon S, Burdge GC, Jones EL, et al. (2006) Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middleaged men. Am J Clin Nutr 83, 744-753.
46. Lambert EV, Goedecke JH, Bluett K, et al. (2007) Conjugated linoleic acid versus high-oleic acid sunflower oil: Effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. Br J Nutr 97, 1001-1011.
47. Nazare JA, de la Perriere AB, Bonnet F, et al. (2007) Daily intake of conjugated linoleic acid-enriched yoghurts: Effects on energy metabolism and adipose tissue gene expression in healthy subjects. Br J Nutr 97, 273-280.
48. American Diabetes Association (2008) Standards of medical care in diabetes. Diabetes Care 31, Suppl. 1, S12-S54.
49. Wanders AJ, Brouwer IA, Siebelink E, et al. (2010) Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects. PLoS One 5, e9000.
50. Brown AW, Trenkle AH & Beitz DC (2011) Diets high in conjugated linoleic acid from pasture-fed cattle did not alter markers of health in young women. Nutr Res 31, 33-41.
51. Mougios V, Matsakas A, Petridou A, et al. (2001) Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem 12, 585-594.
52. Smedman A & Vessby B (2001) Conjugated linoleic acid supplementation in humans - metabolic effects. Lipids 36, 773-781.
53. Thom E, Wadstein J & Gudmundsen O (2001) Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 29, 392-396.
54. Colakoglu S, Colakoglu M, Taneli F, et al. (2006) Cumulative effects of conjugated linoleic acid and exercise on endurance development, body composition, serum leptin and insulin levels. J Sports Med Phys Fitness 46, 570-577.
55. Pinkoski C, Chilibeck PD, Candow DG, et al. (2006) The effects of conjugated linoleic acid supplementation during resistance training. Med Sci Sports Exerc 38, 339-348.
56. Raff M, Tholstrup T, Toubro S, et al. (2009) Conjugated linoleic acids reduce body fat in healthy postmenopausal women. J Nutr 139, 1347-1352.
57. Steck SE, Chalecki AM, Miller P, et al. (2007) Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. J Nutr 137, 1188-1193.
58. Syvertsen C, Halse J, Hoivik HO, et al. (2007) The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. Int J Obes 31, 1148-1154.
59. Berven G, Bye A, Hals O, et al. (2000) Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol 102, 455-462.
60. Risérus U, Arner P, Brismar K, et al. (2002) Treatment with dietary trans10cis12 conjugated linoleic acid causes isomerspecific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25, 1516-1521.
61. Herrmann J, Rubin D, Häsler R, et al. (2009) Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARg2 P12A polymorphism: A double blind, randomized, controlled cross-over study. Lipids Health Dis 18, 35.
62. Sluijs I, Plantinga Y, de Roos B, et al. (2010) Dietary supplementation with cis-9,trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am J Clin Nutr 91, 175-183.
63. Joseph SV, Jacques H, Plourde M, et al. (2011) Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. J Nutr 141, 1286-1291.
64. Blankson H, Stakkestad JA, Fagertun H, et al. (2000) Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 130, 2943-2948.
65. Gaullier JM, Halse J, Hoye K, et al. (2004) Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 79, 1118-1125.
66. Gaullier JM, Halse J, Hoye K, et al. (2005) Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 135, 778-784.
67. Gaullier JM, Halse J, Hoivik HO, et al. (2007) Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. Br J Nutr 97, 550-560.
68. Laso N, Brugué E, Vidal J, et al. (2007) Effects of milk supplementation with conjugated linoleic acid (isomers cis-9trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components. Br J Nutr 98, 860-867.
69. Watras AC, Buchholz AC, Close RN, et al. (2007) The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int J Obes 31, 481-487.
70. Norris LE, Collene AL, Asp ML, et al. (2009) Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. Am J Clin Nutr 90, 468-476.
71. Zhao WS, Zhai JJ, Wang YH, et al. (2009) Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension. Am J Hypertens 22, 680-686.
72. MacRedmond R, Singhera G, Attridge S, et al. (2010) Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics. Clin Exp Allergy 40, 1071-1078.
73. Racine NM, Watras AC, Carrel AL, et al. (2010) Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr 91, 1157-1164.
74. Belury MA, Mahon A & Banni S (2003) The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J Nutr 133, 257S-260S.
75. Whigham LD, Watras AC & Schoeller DA (2007) Efficacy of conjugated linoleic acid for reducing fat mass: A metaanalysis in humans. Am J Clin Nutr 85, 1203-1211.
76. Goedecke JH, Rae DE, Smuts CM, et al. (2009) Conjugated linoleic acid isomers. t10c12 and c9t11, are differentially incorporated into adipose tissue and skeletal muscle in humans. Lipids 44, 983-988.
77. Malpuech-Brugère C, Verboeket-van de Venne WP, Mensink RP, et al. (2004) Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 12, 591-598.
78. Risérus U, Vessby B, Arnlöv J, et al. (2004) Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80, 279-283.
79. Tricon S, Burdge GC, Kew S, et al. (2004) Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 80, 614-620.
80. Desroches S, Chouinard PY, Galibois I, et al. (2005) Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr 82, 309-319.
81. Plourde M, Jew S, Cunnane SC, et al. (2008) Conjugated linoleic acids: Why the discrepancy between animal and human studies? Nutr Rev 66, 415-421.
82. World Health Organization (2009) Cardiovascular diseases (CVDs) Fact Sheet No. 317.http://www.who.int/mediacentre/factsheets/fs317/en/index.html (accessed 12 January 2010)
83. Joint British Societies (2005) Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91, Suppl. 5, 1-52.
84. Keys A, Aravanis C, Blackburn HW, et al. (1966) Epidemiological studies related to coronary heart disease: Characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl 460, 1-392.
85. Mitchell PL & McLeod RS (2008) Conjugated linoleic acid and atherosclerosis: Studies in animal models. Biochem Cell Biol 86, 293-301.
86. Lee KN, Kritchevsky D & Pariza MW (1994) Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108, 19-25.
87. Kritchevsky D, Tepper SA, Wright S, et al. (2000) Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 19, 472S-477S.
88. Kritchevsky D, Tepper SA, Wright S, et al. (2002) Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutr Res 22, 1275-1279.
89. Kritchevsky D, Tepper SA, Wright S, et al. (2004) Conjugated linoleic acid isomer effects in atherosclerosis: Growth and regression of lesions. Lipids 39, 611-616.
90. Nicolosi RJ, Rogers EJ, Kritchevsky D, et al. (1997) Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 22, 266-277.
91. Gavino VC, Gavino G, Leblanc MJ, et al. (2000) An isomeric mixture of conjugated linoleic acids but not pure cis-9 trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr 130, 27-29.
92. Toomey S, Harhen B, Roche HM, et al. (2006) Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 187, 40-49.
93. Arbones-Mainar JM, Navarro MA, Guzman MA, et al. (2006) Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis 189, 318-327.
94. Lock AL, Horne CAM, Bauman DE, et al. (2005) Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein profile in cholesterol-fed hamsters. J Nutr 135, 1934-1939.
95. Valeille K, Férézou J, Amsler G, et al. (2005) A cis-9, trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am J Physiol Heart Circ Physiol 289, 652-659.
96. Faulconnier Y, Roy A, Ferlay A, et al. (2006) Effect of dietary supply of butters rich either in trans-10-181 or in trans-11- 181 plus cis-9 trans-11-182 on rabbit adipose tissue and liver lipogenic activities. Br J Nutr 96, 461-468.
97. Valeille K, Ferezou J, Parquet M, et al. (2006) The natural concentration of the conjugated linoleic acid cis-9,trans- 11, in milk fat has antiatherogenic effects in hyperlipidemic hamsters. J Nutr 136, 1305-1310.
98. Franczyk-Žarów M, Kostogrys RB, Szymczyk B, et al. (2008) Functional effects of eggs, naturally enriched with conjugated linoleic acid, on the blood lipid profile, development of atherosclerosis and composition of atherosclerotic plaque in apolipoprotein E and low-density lipoprotein receptor double-knockout mice (apoE/LDLR2/2). Br J Nutr 99, 49-58.
99. House RL, Cassady JP, Eisen EJ, et al. (2005) Conjugated linoleic acid evokes de-lipidation through the regulation of genes controlling lipid metabolism in adipose and liver tissue. Obes Rev 6, 247-258.
100. Benito P, Nelson GJ, Kelley DS, et al. (2001) The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 36, 229-236.
101. Risérus U, Berglund L & Vessby B (2001) Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: A randomised controlled trial. Int J Obes Relat Metab Disord 25, 1129-1135.
102. Naumann E, Carpentier YA, Saebo A, et al. (2006) Cis-9 trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) do not affect the plasma lipoprotein profile in moderately overweight subjects with LDL phenotype B. Atherosclerosis 188, 167-174.
103. Raff M, Tholstrup T, Basu S, et al. (2008) A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men. J Nutr 138, 509-514.
104. Turpeinen AM, Ylönen N, von Willebrand E, et al. (2008) Immunological and metabolic effects of cis-9 trans-11- conjugated linoleic acid in subjects with birch pollen allergy. Br J Nutr 100, 112-119.
105. Engberink MF, Geleijnse JM, Wanders AJ, et al. (2011) The effect of conjugated linoleic acid, a natural trans fat from milk and meat, on human blood pressure: Results from a randomized crossover feeding study. J Hum Hypertens (epublication ahead of print version 27 January 2011).
106. Noone EJ, Roche HM, Nugent AP, et al. (2002) The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 88, 243-251.
107. Moloney F, Yeow TP, Mullen A, et al. (2004) Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 80, 887-895.
108. Ridker PM, Stampfer MJ & Rifai N (2001) Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285, 2481-2485.
109. Lewington S, Whitlock G, Clarke R, et al. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 370, 1829-1839.
110. Sofi F, Buccioni A, Cesari F, et al. (2009) Effects of a dairy product (pecorino cheese) naturally rich in cis-9 trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: A dietary intervention study. Nutr Metab Cardiovasc Dis 20, 117-124.
111. Lichtenstein AH, Ausman LM, Jalbert SM, et al. (1999) Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 340, 1933-1940.
112. Willett WC, Stampfer MJ, Manson JE, et al. (1993) Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341, 581-585.
113. Mozaffarian D, Katan MB, Ascherio A, et al. (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354, 1601-1613.
114. Chardigny JM, Destaillats F, Malpuech-Brugère C, et al. (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87, 558-566.
115. Mensink RP & Nestel P (2009) Trans fatty acids and cardiovascular risk markers: Does the source matter? Curr Opin Lipidol 20, 1-2.
116. Mensink RP (2005) Metabolic and health effects of isomeric fatty acids. Curr Opin Lipidol 16, 27-30.
117. Turpeinen AM, Mutanen M, Aro A, et al. (2002) Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76, 504-510.
118. Libby P, Ridker PM & Hansson GK (2009) Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol 54, 2129-2138.
119. Gade W, Schmit J, Collins M, et al. (2010) Beyond obesity: The diagnosis and pathophysiology of metabolic syndrome. Clin Lab Sci 23, 51-61.
120. Yu Y, Correll PH & Vanden Heuvel JP (2002) Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: Evidence for a PPARg-dependent mechanism. Biochim Biophys Acta 1581, 89-99.
121. Jaudszus A, Foerster M, Kroegel C, et al. (2005) Cis-9,trans- 11-CLA exerts anti-inflammatory effects in human bronchial epithelial cells and eosinophils: Comparison to trans-10,cis- 12-CLA and to linoleic acid. Biochim Biophys Acta 1737, 111-118.
122. Loscher CE, Draper E, Leavy O, et al. (2005) Conjugated linoleic acid suppresses NF-kB activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J Immunol 175, 4990-4998.
123. Reynolds CM, Loscher CE, Moloney AP, et al. (2008) Cis-9 trans-11-conjugated linoleic acid but not its precursor trans-vaccenic acid attenuate inflammatory markers in the human colonic epithelial cell line Caco-2. Br J Nutr 100, 13-17.
124. Stachowska E, Dolegowska B, Dziedziejko V, et al. (2009) Prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) synthesis is regulated by conjugated linoleic acids (CLA) in human macrophages. J Physiol Pharmacol 60, 77-85.
125. Changhua L, Jindong Y, Defa L, et al. (2005) Conjugated linoleic acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide. J Nutr 135, 239-244.
126. Butz DE, Li G, Huebner SM, et al. (2007) A mechanistic approach to understanding conjugated linoleic acid's role in inflammation using murine models of rheumatoid arthritis. Am J Physiol Regul Integr Comp Physiol 293, R669-R676.
127. Noto A, Zahradka P, Ryz NR, et al. (2007) Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats. Metabolism 56, 142-151.
128. LaRosa PC, Miner J, Xia Y, et al. (2006) Trans-10 cis-12 conjugated linoleic acid causes inflammation and delipidation of white adipose tissue in mice: A microarray and histological analysis. Physiol Genomics 27, 282-294.
129. Poirier H, Shapiro JS, Kim RJ, et al. (2006) Nutritional supplementation with trans-10 cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes 55, 1634-1641.
130. Smedman A, Basu S, Jovinge S, et al. (2005) Conjugated linoleic acid increased C-reactive protein in human subjects. Br J Nutr 94, 791-795.
131. Tholstrup T, Raff M, Straarup EM, et al. (2008) An oil mixture with trans-10 cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. J Nutr 138, 1445-1451.
132. MacRedmond R, Singhera G, Attridge S, et al. (2010) Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics. Clin Exp Allergy 40, 1071-1078.
133. Stickford JL, Mickleborough TD, Fly AD, et al. (2011) Conjugated linoleic acid's lack of attenuation of hyperpneainduced bronchoconstriction in asthmatic individuals in the short term. Int J Sport Nutr Exerc Metab 21, 40-47.
134. Tricon S, Burdge GC, Kew S, et al. (2004) Effects of cis-9, trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am J Clin Nutr 80, 1626-1633.
135. Ramakers JD, Plat J, Sebedio JL, et al. (2005) Effects of the individual isomers cis-9,trans-11 vs trans-10,cis-12 of conjugated linoleic acid (CLA) on inflammation parameters in moderately overweight subjects with LDL-phenotype B. Lipids 40, 909-918.
136. Risérus U, Basu S, Jovinge S, et al. (2002) Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: A potential link to fatty acid-induced insulin resistance. Circulation 106, 1925-1929.
137. Kelley DS, Taylor PC, Rudolph IL, et al. (2000) Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids 35, 1065-1071.
138. Nugent AP, Roche HM, Noone EJ, et al. (2005) The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers. Eur J Clin Nutr 59, 742-750.
139. Song HJ, Grant I, Rotondo D, et al. (2005) Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr 59, 508-517.
140. Mullen A, Moloney F, Nugent AP, et al. (2007) Conjugated linoleic acid supplementation reduces peripheral blood mononuclear cell interleukin-2 production in healthy middle-aged males. J Nutr Biochem 18, 658-666.
141. Taylor CG & Zahradka P (2004) Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models. Am J Clin Nutr 79, 1164S-1168S.
142. Belury MA (2002) Dietary conjugated linoleic acid in health: Physiological effects and mechanisms of action. Annu Rev Nutr 22, 505-531.
143. Roche HM, Noone E, Sewter C, et al. (2002) Isomer-dependent metabolic effects of conjugated linoleic acid: Insights from molecular markers sterol regulatory element-binding protein-1c and LXRa. Diabetes 51, 2037-2044.
144. Moloney F, Toomey S, Noone E, et al. (2007) Antidiabetic effects of cis-9 trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes 56, 574-582.
145. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, et al. (1998) Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 244, 678-682.
146. Ryder JW, Portocarrero CP, Song XM, et al. (2001) Isomerspecific antidiabetic properties of conjugated linoleic acid Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 50, 1149-1157.
147. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, et al. (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534-1542.
148. Halade GV, Rahman MM & Fernandes G (2009) Effect of CLA isomers and their mixture on aging C57Bl/6J mice. Eur J Nutr 48, 409-418.
149. Halade GV, Rahman MM & Fernandes G (2009) Differential effects of conjugated linoleic acid isomers in insulin-resistant female C57Bl/6J mice. J Nutr Biochem 21, 332-337.
150. de Roos B, Rucklidge G, Reid M, et al. (2005) Divergent mechanisms of cis9 trans11-and trans10, cis12-conjugated linoleic acid affecting insulin resistance and inflammation in apolipoprotein E knockout mice: A proteomics approach. FASEB J 19, 1746-1748.
151. de Roos B & McArdle HJ (2008) Proteomics as a tool for the modelling of biological processes and biomarker development in nutrition research. Br J Nutr 99, S66-S71.
152. Risérus U, Smedman A, Basu S, et al. (2004) Metabolic effects of conjugated linoleic acid in humans: The Swedish experience. Am J Clin Nutr 79, 1146S-1148S.
153. Ahren B, Mari A, Fyfe CL, et al. (2009) Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men. Eur J Clin Nutr 63, 778-786.
154. Tarnopolsky M, Zimmer A, Paikin J, et al. (2007) Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS One 2, e991.
155. Eyjolfson V, Spriet LL & Dyck DJ (2004) Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc 36, 814-820.
156. Risérus U (2006) Trans fatty acids and insulin resistance. Atheroscler Suppl 7, 37-39.
157. Alberti KG, Eckel RH, Grundy SM, et al. (2009) Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645.
158. Prentice A, Schoenmakers I, Laskey MA, et al. (2006) Nutrition and bone growth and development. Proc Nutr Soc 65, 348-360.
159. National Osteoporosis Society (2009) National Osteoporosis Society http://www.nos.org.uk/NetCommunity/(accessed 20 October 2009).
160. Lanham-New SA (2008) Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment. Proc Nutr Soc 67, 163-176.
161. Roy BD & Antolic AM (2009) Conjugated linoleic acid (CLA) and bone health: A review. Curr Topics Nutraceutical Res 7, 27-36.
162. Hur SJ & Park Y (2007) Effect of conjugated linoleic acid on bone formation and rheumatoid arthritis. Eur J Pharmacol 568, 16-24.
163. Watkins BA & Seifert MF (2000) Conjugated linoleic acid and bone biology. J Am Coll Nutr 19, 478S-486S.
164. Kelly O & Cashman KD (2004) The effect of conjugated linoleic acid on calcium absorption and bone metabolism and composition in adult ovariectomised rats. Prostaglandins Leukot Essent Fatty Acids 71, 295-301.
165. Kelly O, Cusack S, Jewell C, et al. (2003) The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats. Br J Nutr 90, 743-750.
166. Li Y & Watkins BA (1998) Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids 33, 417-425.
167. Li Y, Seifert MF, Ney DM, et al. (1999) Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res 14, 1153-1162.
168. Watkins BA, Shen CL, McMurtry JP, et al. (1997) Dietary lipids modulate bone prostaglandin E2 production, insulin- like growth factor-I concentration and formation rate in chicks. J Nutr 127, 1084-1091.
169. Jewell C & Cashman KD (2003) The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells. Br J Nutr 89, 639-647.
170. Park Y, Pariza MW & Park Y (2008) Cosupplementation of dietary calcium and conjugated linoleic acid (CLA) improves bone mass in mice. J Food Sci 73, C556-C560.
171. Weiler H, Austin S, Fitzpatrick-Wong S, et al. (2004) Conjugated linoleic acid reduces parathyroid hormone in health and in polycystic kidney disease in rats. Am J Clin Nutr 79, 1186S-1189S.
172. Weiler HA, Fitzpatrick S & Fitzpatrick-Wong SC (2008) Dietary conjugated linoleic acid in the cis-9 trans-11 isoform reduces parathyroid hormone in male, but not female, rats. J Nutr Biochem 19, 762-769.
173. Brownbill RA, Petrosian M & Ilich JZ (2005) Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. J AmCollNutr 24, 177-181.
174. Doyle L, Jewell C, Mullen A, et al. (2005) Effect of dietary supplementation with conjugated linoleic acid on markers of calcium and bone metabolism in healthy adult men. Eur J Clin Nutr 59, 432-440.
175. Kreider RB, Ferreira MP, Greenwood M, et al. (2002) Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res 16, 325-334.
176. Kant AK & Graubard BI (2006) Secular trends in patterns of self-reported food consumption of adult Americans: NHANES 1971-1975 to NHANES 1999-2002. Am J Clin Nutr 84, 1215-1223.